Public Market Listing
ZEALNasdaq Copenhagen
Live quotes, historical charts, and market capitalization for Zealand Pharma are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(5 total)
5Total Assets
0Approved
3Phase 3 / Filed
2Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
dasiglucagon(Zegalogue) | Phase 3 | Glucagon receptor (agonist)Peptide | Type 2 Diabetes |
| Phase 3 | Amylin receptor · Amylin/calcitonin receptor (dual)Peptide | Obesity | |
| Phase 3 | GLP-1/glucagon receptor (dual)Peptide | ObesityType 2 DiabetesMASH / NASH | |
| Phase 2 | GLP-1 receptorPeptide | Obesity | |
| Phase 1 | GIP receptorPeptide | Obesity |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.